Drug Treatment of Benign Prostatic Hyperplasia and Hospital Admission for BPH-Related Surgery
Authors:
- P.C SouvereinPSP.C Souverein
- J.A ErkensJEJ.A Erkens
- J.J.M.C.H de la RosetteJRJ.J.M.C.H de la Rosette
- H.G.M LeufkensHLH.G.M Leufkens
- R.M.C HeringsRHR.M.C Herings
- 1 May 2003
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 43 (5) , 528-534
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 yearsUrology, 1999
- A Meta-Analysis on the Efficacy and Tolerability of α1-Adrenoceptor Antagonists in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic ObstructionEuropean Urology, 1999
- Clinical Uroselectivity: A 3-Year Follow-Up in General PracticeEuropean Urology, 1998
- Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-lifeArchives of internal medicine (1960), 1995
- Tamsulosin, a selective α 1c ‐adrenoceptor* antagonist: a randomized, controlled trial in patients with benign prostatic ‘obstruction’ (symptomatic BPH)British Journal of Urology, 1995
- Hypoglycaemia associated with use of inhibitors of angiotensin converting enzymeThe Lancet, 1995
- Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasiaUrology, 1995
- Therapeutic controversies: clinical treatment of benign prostatic hyperplasiaThe Journal of Clinical Endocrinology & Metabolism, 1995
- A chronic disease score from automated pharmacy dataJournal of Clinical Epidemiology, 1992
- The Development of Human Benign Prostatic Hyperplasia with AgeJournal of Urology, 1984